drugset / Trial / NCT03265964

Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

NCT03265964

Phase 4 Completed 75 enrolled VA Office of Research and Development
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled study of the investigational drug uridine as a treatment for suicidal ideation in veterans. The investigators hypothesize that the administration of a naturally occurring dietary supplement, uridine, will rapidly reduce suicidal ideation in veterans. The purpose of this study is to determine whether 4 weeks of uridine supplementation is an effective treatment for suicidal ideation in veterans, when compared to a group taking a placebo.

Timeline

Start
2018-04-02
Primary completion
2024-06-30
Completion
2024-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Uridine Small molecule 2000 mg Oral

Indications

No indication recorded.